Afinida, Inc.
TREP · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2 | $2 | $3 | $2 |
| - Cash | $0 | $0 | $4 | $3 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $2 | -$1 | -$1 |
| Revenue | $6 | $5 | $6 | $6 |
| % Growth | 15.4% | -17.7% | 5.8% | – |
| Gross Profit | $2 | $2 | $3 | $3 |
| % Margin | 29.8% | 46.6% | 57.1% | 54% |
| EBITDA | -$1 | -$1 | $0 | $0 |
| % Margin | -8.9% | -16.7% | 4.6% | 6.9% |
| Net Income | -$1 | -$1 | $0 | -$0 |
| % Margin | -9.4% | -18.3% | 1.3% | -0.9% |
| EPS Diluted | -0.01 | -0.016 | 0.002 | -0.001 |
| % Growth | 41.1% | -1,186.7% | 266.7% | – |
| Operating Cash Flow | -$0 | -$3 | $1 | -$14 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$3 | $1 | -$14 |